PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE

Autor: Oliva, Anthony A., Jr., Baumel, Bernard, Brody, Mark, Agronin, Marc, Drouillard, Amy, Pena, Andrea, McClain-Moss, Lisa, Page, Suzanne L., Perez, Carmen, Landman, Jonathan, Alston, Tequesta, Bookheimer, Susan Y., Castaneda, Ricardo, Hare, Joshua M.
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2019 15(7) Supplement:P586-P586
Databáze: ScienceDirect